1108 related articles for article (PubMed ID: 25639558)
1. Celiac disease evolving into dermatitis herpetiformis in patients adhering to normal or gluten-free diet.
Salmi TT; Hervonen K; Kurppa K; Collin P; Kaukinen K; Reunala T
Scand J Gastroenterol; 2015 Apr; 50(4):387-92. PubMed ID: 25639558
[TBL] [Abstract][Full Text] [Related]
2. Prognosis of Dermatitis Herpetiformis Patients with and without Villous Atrophy at Diagnosis.
Mansikka E; Hervonen K; Kaukinen K; Collin P; Huhtala H; Reunala T; Salmi T
Nutrients; 2018 May; 10(5):. PubMed ID: 29783727
[TBL] [Abstract][Full Text] [Related]
3. Dermatitis Herpetiformis Refractory to Gluten-free Dietary Treatment.
Hervonen K; Salmi TT; Ilus T; Paasikivi K; Vornanen M; Laurila K; Lindfors K; Viiri K; Saavalainen P; Collin P; Kaukinen K; Reunala T
Acta Derm Venereol; 2016 Jan; 96(1):82-6. PubMed ID: 26084552
[TBL] [Abstract][Full Text] [Related]
4. Dermatitis herpetiformis: a cutaneous manifestation of coeliac disease.
Collin P; Salmi TT; Hervonen K; Kaukinen K; Reunala T
Ann Med; 2017 Feb; 49(1):23-31. PubMed ID: 27499257
[TBL] [Abstract][Full Text] [Related]
5. Gluten Challenge Induces Skin and Small Bowel Relapse in Long-Term Gluten-Free Diet-Treated Dermatitis Herpetiformis.
Mansikka E; Hervonen K; Kaukinen K; Ilus T; Oksanen P; Lindfors K; Laurila K; Hietikko M; Taavela J; Jernman J; Saavalainen P; Reunala T; Salmi T
J Invest Dermatol; 2019 Oct; 139(10):2108-2114. PubMed ID: 30998982
[TBL] [Abstract][Full Text] [Related]
6. Quality of Life and Gastrointestinal Symptoms in Long-Term Treated Dermatitis Herpetiformis Patients: A Cross-Sectional Study in Finland.
Pasternack C; Kaukinen K; Kurppa K; Mäki M; Collin P; Reunala T; Huhtala H; Salmi T
Am J Clin Dermatol; 2015 Dec; 16(6):545-52. PubMed ID: 26267424
[TBL] [Abstract][Full Text] [Related]
7. Autoantibodies against epidermal transglutaminase are a sensitive diagnostic marker in patients with dermatitis herpetiformis on a normal or gluten-free diet.
Rose C; Armbruster FP; Ruppert J; Igl BW; Zillikens D; Shimanovich I
J Am Acad Dermatol; 2009 Jul; 61(1):39-43. PubMed ID: 19344979
[TBL] [Abstract][Full Text] [Related]
8. Small bowel transglutaminase 2-specific IgA deposits in dermatitis herpetiformis.
Salmi TT; Hervonen K; Laurila K; Collin P; Mäki M; Koskinen O; Huhtala H; Kaukinen K; Reunala T
Acta Derm Venereol; 2014 Jul; 94(4):393-7. PubMed ID: 24352382
[TBL] [Abstract][Full Text] [Related]
9. [Dermatitis herpetiformis occuring in patients with celiac disease in childhood].
Démoulins-Giacco N; Gagey V; Teillac-Hamel D; Fraitag S; Caillat-Zucman S; Schmitz J; de Prost Y
Arch Pediatr; 1996 Jun; 3(6):541-8. PubMed ID: 8881298
[TBL] [Abstract][Full Text] [Related]
10. Dermatitis herpetiformis.
Salmi TT
Clin Exp Dermatol; 2019 Oct; 44(7):728-731. PubMed ID: 31093998
[TBL] [Abstract][Full Text] [Related]
11. Serum IL-8 in patients with dermatitis herpetiformis is produced in response to dietary gluten.
Hall RP; Benbenisty KM; Mickle C; Takeuchi F; Streilein RD
J Invest Dermatol; 2007 Sep; 127(9):2158-65. PubMed ID: 17597819
[TBL] [Abstract][Full Text] [Related]
12. Dietary management of dermatitis herpetiformis.
Hall RP
Arch Dermatol; 1987 Oct; 123(10):1378a-1380a. PubMed ID: 3662571
[TBL] [Abstract][Full Text] [Related]
13. Reduced mortality in dermatitis herpetiformis: a population-based study of 476 patients.
Hervonen K; Alakoski A; Salmi TT; Helakorpi S; Kautiainen H; Kaukinen K; Pukkala E; Collin P; Reunala T
Br J Dermatol; 2012 Dec; 167(6):1331-7. PubMed ID: 22708883
[TBL] [Abstract][Full Text] [Related]
14. Diagnosing mild enteropathy celiac disease: a randomized, controlled clinical study.
Kurppa K; Collin P; Viljamaa M; Haimila K; Saavalainen P; Partanen J; Laurila K; Huhtala H; Paasikivi K; Mäki M; Kaukinen K
Gastroenterology; 2009 Mar; 136(3):816-23. PubMed ID: 19111551
[TBL] [Abstract][Full Text] [Related]
15. Wheat starch-containing gluten-free flour products in the treatment of coeliac disease and dermatitis herpetiformis. A long-term follow-up study.
Kaukinen K; Collin P; Holm K; Rantala I; Vuolteenaho N; Reunala T; Mäki M
Scand J Gastroenterol; 1999 Feb; 34(2):163-9. PubMed ID: 10192194
[TBL] [Abstract][Full Text] [Related]
16. Dermatitis Herpetiformis: An Update on Diagnosis and Management.
Reunala T; Hervonen K; Salmi T
Am J Clin Dermatol; 2021 May; 22(3):329-338. PubMed ID: 33432477
[TBL] [Abstract][Full Text] [Related]
17. The Decreasing Prevalence of Severe Villous Atrophy in Dermatitis Herpetiformis: A 45-Year Experience in 393 Patients.
Mansikka E; Hervonen K; Salmi TT; Kautiainen H; Kaukinen K; Collin P; Reunala T
J Clin Gastroenterol; 2017 Mar; 51(3):235-239. PubMed ID: 27136959
[TBL] [Abstract][Full Text] [Related]
18. Serum transglutaminase 3 antibodies correlate with age at celiac disease diagnosis.
Salmi TT; Kurppa K; Hervonen K; Laurila K; Collin P; Huhtala H; Saavalainen P; Sievänen H; Reunala T; Kaukinen K
Dig Liver Dis; 2016 Jun; 48(6):632-7. PubMed ID: 27026081
[TBL] [Abstract][Full Text] [Related]
19. Dermatitis herpetiformis: pathognomonic transglutaminase IgA deposits in the skin and excellent prognosis on a gluten-free diet.
Reunala T; Salmi TT; Hervonen K
Acta Derm Venereol; 2015 Nov; 95(8):917-22. PubMed ID: 26059085
[TBL] [Abstract][Full Text] [Related]
20. Benefits of a gluten-free diet for asymptomatic patients with serologic markers of celiac disease.
Kurppa K; Paavola A; Collin P; Sievänen H; Laurila K; Huhtala H; Saavalainen P; Mäki M; Kaukinen K
Gastroenterology; 2014 Sep; 147(3):610-617.e1. PubMed ID: 24837306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
